147 related articles for article (PubMed ID: 30242791)
1. Ingenol mebutate versus imiquimod versus diclofenac for actinic cheilitis: a 6-month follow-up clinical study.
Husein-ElAhmed H; Almazan-Fernandez FM; Husein-ElAhmed S
Clin Exp Dermatol; 2019 Mar; 44(2):231-234. PubMed ID: 30242791
[No Abstract] [Full Text] [Related]
2. Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.
Elías I; Ortega-Joaquín N; de la Cueva P; Del Pozo LJ; Moreno-Ramírez D; Boada A; Aguilar M; Mirada A; Mosquera E; Gibbons C; Oyagüez I
Actas Dermosifiliogr; 2016; 107(6):498-508. PubMed ID: 27130804
[TBL] [Abstract][Full Text] [Related]
3. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
4. Management of actinic cheilitis using ingenol mebutate gel: A report of seven cases.
Flórez Á; Batalla A; de la Torre C
J Dermatolog Treat; 2017 Mar; 28(2):149-151. PubMed ID: 27241280
[TBL] [Abstract][Full Text] [Related]
5. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
[TBL] [Abstract][Full Text] [Related]
6. Treatments of actinic cheilitis: A systematic review of the literature.
Lai M; Pampena R; Cornacchia L; Pellacani G; Peris K; Longo C
J Am Acad Dermatol; 2020 Sep; 83(3):876-887. PubMed ID: 31400450
[TBL] [Abstract][Full Text] [Related]
7. Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis.
Tzika E; Masouyé I; Mühlstädt M; Laffitte E
Dermatology; 2016; 232 Suppl 1():1-3. PubMed ID: 27513668
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac sodium gel therapy as an alternative to actinic cheilitis.
Gonzaga AKG; de Oliveira PT; da Silveira ÉJD; Queiroz LMG; de Medeiros AMC
Clin Oral Investig; 2018 Apr; 22(3):1319-1325. PubMed ID: 28986686
[TBL] [Abstract][Full Text] [Related]
9. Actinic keratosis - review for clinical practice.
de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
[TBL] [Abstract][Full Text] [Related]
10. Ingenol mebutate gel treatment for actinic cheilitis: report of four cases.
Barrado Solís N; Molés Poveda P; Lloret Ruiz C; Pont Sanjuan V; Velasco Pastor M; Quecedo Estébanez E; Miquel Miquel J
Dermatol Ther; 2015; 28(2):79-82. PubMed ID: 25545762
[TBL] [Abstract][Full Text] [Related]
11. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Herms F
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS22-IIS30. PubMed ID: 31133226
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive diagnosis and monitoring of actinic cheilitis with reflectance confocal microscopy.
Ulrich M; González S; Lange-Asschenfeldt B; Roewert-Huber J; Sterry W; Stockfleth E; Astner S
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):276-84. PubMed ID: 20626536
[TBL] [Abstract][Full Text] [Related]
14. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis.
Lima Gda S; Silva GF; Gomes AP; de Araújo LM; Salum FG
J Appl Oral Sci; 2010; 18(5):533-7. PubMed ID: 21085813
[TBL] [Abstract][Full Text] [Related]
15. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
[TBL] [Abstract][Full Text] [Related]
16. Use of topical anti-inflammatory and antineoplastic agents in the treatment of young-aged actinic cheilitis: A systematic review.
Medeiros CKS; de França GM; Lima JGDC; Pinheiro JC; Almeida DRMF; Santos PPA
J Cosmet Dermatol; 2022 Feb; 21(2):473-481. PubMed ID: 33786961
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece.
Athanasakis K; Boubouchairopoulou N; Tarantilis F; Tsiantou V; Kontodimas S; Kyriopoulos J
Clin Ther; 2017 May; 39(5):993-1002. PubMed ID: 28449867
[TBL] [Abstract][Full Text] [Related]
18. Ingenol mebutate gel for the treatment of molluscum contagiosum: An open-label comparative pilot study.
Shin K; Bae KN; Kim HS; Kim BS; Kim MB; Ko HC
J Am Acad Dermatol; 2020 Jan; 82(1):254-255. PubMed ID: 31499155
[No Abstract] [Full Text] [Related]
19. Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.
Norrlid H; Norlin JM; Holmstrup H; Malmberg I; Sartorius K; Thormann H; Jemec GBE; Ragnarson Tennvall G
J Dermatolog Treat; 2018 Feb; 29(1):68-73. PubMed ID: 28658998
[TBL] [Abstract][Full Text] [Related]
20. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
